Periorbital infections caused by Group A streptococci: a case series. | Canada Hyperbarics Skip to main content
Retrospective Study BMC infectious diseases 2026

Periorbital infections caused by Group A streptococci: a case series.

Tinggaard M, Johannesen TB, Hoffmann S, Andersen AB, Toft PB — BMC infectious diseases, 2026

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a single-center retrospective case series at the University Hospital of Copenhagen, reviewing 11 adult patients with culture-confirmed periorbital Group A streptococcus infections over a 14-month period.

What They Found

The study included 11 patients with periorbital GAS infections, with a median age of 72 years; four patients had diabetes and two developed septic shock. Six cases were diagnosed with pre-septal cellulitis, while five had post-septal necrotizing soft tissue infection (NSTI) confirmed by surgery, with these NSTI cases showing the MLST 28 / emm 1.0 (M1 clone) GAS type.

What This Means for Canadian Patients

Canadian clinicians should maintain a high index of suspicion for Group A streptococcus in patients presenting with severe periorbital infections, especially given the post-COVID-19 surge. Early recognition and appropriate treatment, including surgical debridement for necrotizing soft tissue infection, are crucial to improve outcomes for Canadian patients.

Canadian Relevance

This study has no direct Canadian connection as it was conducted at a single center in Copenhagen, Denmark.

Study Limitations

The study's retrospective, single-center design and small sample size limit the generalizability of its findings.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Infection
Source Pubmed
PubMed ID 41545920
Year Published 2026
Journal BMC infectious diseases
MeSH Terms Humans; Middle Aged; Male; Aged; Female; Streptococcus pyogenes; Streptococcal Infections; Retrospective Studies; Aged, 80 and over; Soft Tissue Infections; COVID-19; Anti-Bacterial Agents; SARS-CoV-2; Fasciitis, Necrotizing

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.